X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (8401) 8401
Publication (583) 583
Book / eBook (142) 142
Book Chapter (78) 78
Book Review (76) 76
Magazine Article (28) 28
Conference Proceeding (9) 9
Web Resource (6) 6
Dissertation (4) 4
Reference (3) 3
Government Document (1) 1
Journal / eJournal (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (7737) 7737
female (4323) 4323
male (4305) 4305
middle aged (3716) 3716
aged (3528) 3528
index medicus (2638) 2638
adult (2629) 2629
surgery (1713) 1713
gastroenterology & hepatology (1614) 1614
oncology (1541) 1541
cancer (1392) 1392
aged, 80 and over (1329) 1329
treatment outcome (1080) 1080
retrospective studies (1054) 1054
cholangiocarcinoma (1037) 1037
biliary tract neoplasms - pathology (893) 893
carcinoma (868) 868
biliary tract (841) 841
prognosis (838) 838
liver (750) 750
bile duct neoplasms - pathology (730) 730
chemotherapy (708) 708
bile duct neoplasms - surgery (688) 688
biliary tract neoplasms - surgery (676) 676
medicine & public health (664) 664
risk factors (642) 642
diagnosis (584) 584
diagnosis, differential (584) 584
biliary tract neoplasms - diagnosis (572) 572
biliary tract neoplasms - drug therapy (555) 555
tumors (554) 554
gemcitabine (502) 502
neoplasm staging (500) 500
pathology (500) 500
biliary tract diseases - diagnosis (498) 498
survival rate (498) 498
animals (497) 497
cholangiocarcinoma - pathology (484) 484
tomography, x-ray computed (480) 480
gallbladder (478) 478
biliary-tract (477) 477
gallbladder cancer (477) 477
cholangiography (471) 471
stents (471) 471
survival (462) 462
biliary tract cancer (460) 460
pancreatic neoplasms - surgery (453) 453
biliary tract neoplasms - complications (448) 448
cholestasis - etiology (446) 446
radiology, nuclear medicine & medical imaging (439) 439
pancreatic neoplasms - diagnosis (433) 433
cholangiopancreatography, endoscopic retrograde (426) 426
gastroenterology (420) 420
management (414) 414
liver neoplasms - surgery (411) 411
follow-up studies (410) 410
bile (409) 409
bile duct neoplasms - diagnosis (408) 408
analysis (407) 407
biliary tract diseases - surgery (406) 406
biliary tract neoplasms - mortality (404) 404
intrahepatic cholangiocarcinoma (400) 400
pancreas (398) 398
deoxycytidine - analogs & derivatives (395) 395
bile ducts, intrahepatic (388) 388
gallbladder neoplasms - pathology (382) 382
antineoplastic combined chemotherapy protocols - therapeutic use (381) 381
research (381) 381
hilar cholangiocarcinoma (378) 378
adolescent (377) 377
cholangiocarcinoma - surgery (364) 364
pancreatic neoplasms - pathology (362) 362
survival analysis (361) 361
immunohistochemistry (359) 359
ultrasonography (354) 354
biliary tract diseases - diagnostic imaging (350) 350
biliary-tract cancer (346) 346
liver neoplasms - pathology (342) 342
pancreatic cancer (342) 342
neoplasms (341) 341
palliative care (339) 339
drainage (338) 338
time factors (337) 337
care and treatment (336) 336
biliary tract neoplasms - therapy (334) 334
adenocarcinoma (329) 329
prospective studies (329) 329
patients (328) 328
hepatectomy (327) 327
mortality (326) 326
hepatocellular-carcinoma (325) 325
pancreatic neoplasms - complications (325) 325
biliary tract surgical procedures (322) 322
health aspects (322) 322
biliary tract neoplasms (317) 317
bile ducts, intrahepatic - pathology (309) 309
bile duct neoplasms - mortality (304) 304
liver neoplasms - diagnosis (302) 302
gallbladder neoplasms - surgery (299) 299
endoscopy (295) 295
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (99) 99
Online Resources - Online (7) 7
Collection Dvlpm't (Acquisitions) - Closed Orders (4) 4
Scarborough Hospital - General (2) 2
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (2) 2
Collection Dvlpm't (Acquisitions) - Vendor file (1) 1
Credit Valley Hospital - Reference (1) 1
Gerstein Science - Reference (1) 1
Humber River Regional Hospital - Church Stacks (1) 1
Lakeridge Health Sciences - Oshawa (1) 1
Providence Healthcare - Reference (1) 1
Scarborough Hospital - Online (1) 1
St. Michael's Hospital - Stacks (1) 1
Sunnybrook Health Sciences Centre - Online (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Reference (1) 1
UofT at Mississauga - Oversize (1) 1
UofT at Mississauga - Reference (1) 1
UofT at Mississauga - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (7037) 7037
Japanese (395) 395
German (331) 331
French (226) 226
Italian (157) 157
Russian (155) 155
Spanish (107) 107
Chinese (52) 52
Korean (36) 36
Polish (35) 35
Romanian (24) 24
Czech (18) 18
Bulgarian (14) 14
Dutch (14) 14
Hungarian (13) 13
Danish (12) 12
Portuguese (12) 12
Norwegian (8) 8
Croatian (5) 5
Swedish (4) 4
Ukrainian (4) 4
Arabic (3) 3
Serbian (3) 3
Turkish (3) 3
Afar (1) 1
Finnish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


2014, Second edition., Medical radiology. Radiation oncology, ISBN 3642405576
Web Resource
Lancet Oncology, The, ISSN 1470-2045, 2012, Volume 13, Issue 2, pp. 181 - 188
Summary Background Combination chemotherapy with gemcitabine and a platinum-based agent is regarded as a standard treatment for patients with advanced... 
Hematology, Oncology and Palliative Medicine | PLUS GEMCITABINE | CHOLANGIOCARCINOMA | CISPLATIN | ONCOLOGY | ADENOCARCINOMA | PANCREATIC-CANCER | CLINICAL-TRIALS | II TRIAL | COMBINATION | CHEMOTHERAPY | GALL-BLADDER CANCER | Erlotinib Hydrochloride | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Deoxycytidine - therapeutic use | Neoplasm Metastasis | Organoplatinum Compounds - administration & dosage | Deoxycytidine - adverse effects | Female | Quinazolines - administration & dosage | Biliary Tract Neoplasms - drug therapy | Biliary Tract Neoplasms - pathology | Gallbladder Neoplasms - epidemiology | Cholangiocarcinoma - epidemiology | Deoxycytidine - administration & dosage | Biliary Tract Neoplasms - epidemiology | Disease Progression | Disease-Free Survival | Cholangiocarcinoma - pathology | Gallbladder Neoplasms - drug therapy | Cholangiocarcinoma - drug therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Quinazolines - therapeutic use | Quinazolines - adverse effects | Aged | Gallbladder Neoplasms - pathology | Neoplasm Staging | Organoplatinum Compounds - therapeutic use | Deoxycytidine - analogs & derivatives | Organoplatinum Compounds - adverse effects | Medical colleges | Chemotherapy | Erlotinib | Gemcitabine | Pancreatic cancer | Oncology, Experimental | Clinical trials | Research | Drug therapy, Combination | Cancer
Journal Article
Cancer Imaging, ISSN 1470-7330, 2007, Volume 7, Issue Special Issue A, pp. S15 - S23
Most biliary tract neoplasms are malignant and have been traditionally divided into cancers of the gallbladder, the extrahepatic bile ducts, and ampulla of... 
MRI | MRCP | ERCP | MDCT | Ultrasound | Cholangiocarcinoma | Gallbladder cancer | Diagnostic Imaging | Diagnosis, Differential | Neoplasm Staging | Humans | Biliary Tract Neoplasms - diagnosis | Biliary Tract Neoplasms - pathology
Journal Article
Cancer Letters, ISSN 0304-3835, 2017, Volume 402, pp. 9 - 15
Abstract The human intestinal microbiome encompasses at least 100 trillion microorganisms that can influence host immunity and disease conditions, including... 
Hematology, Oncology and Palliative Medicine | Pancreatic adenocarcinoma | Bacteria | Hepatocellular carcinoma | Gut–liver axis | Cholangiocarcinoma | BILIARY-TRACT CANCER | INTESTINAL MICROBIOTA | FATTY LIVER-DISEASE | LONG-TERM SURVIVAL | RANDOMIZED CONTROLLED-TRIAL | GUT MICROBIOTA | FUSOBACTERIUM-NUCLEATUM | HEPATOCELLULAR-CARCINOMA | ONCOLOGY | POSTOPERATIVE INFECTIOUS COMPLICATIONS | HELICOBACTER-HEPATICUS | Gut-liver axis | Immunotherapy - methods | Humans | Antineoplastic Agents - therapeutic use | Liver Neoplasms - therapy | Dysbiosis | Gastrointestinal Tract - immunology | Gastrointestinal Tract - surgery | Biliary Tract Neoplasms - therapy | Liver Neoplasms - pathology | Biliary Tract Neoplasms - pathology | Biliary Tract Neoplasms - microbiology | Pancreatic Neoplasms - pathology | Gastrointestinal Tract - microbiology | Gastrointestinal Tract - drug effects | Liver Neoplasms - immunology | Biliary Tract Neoplasms - immunology | Liver Neoplasms - microbiology | Host-Pathogen Interactions | Cell Transformation, Neoplastic - immunology | Animals | Digestive System Surgical Procedures | Pancreatic Neoplasms - immunology | Pancreatic Neoplasms - microbiology | Gastrointestinal Microbiome - immunology | Cell Transformation, Neoplastic - pathology | Pancreatic Neoplasms - therapy | Microbiota (Symbiotic organisms) | Liver | College graduates | Development and progression | Metastasis | Liver cancer | Chemotherapy | Metabolites | Cell death | Analysis | Pancreatic cancer | Immunotherapy | Cancer | Animal models | DNA damage | Clinical trials | Immunity | Metastases | Hepatitis | Microorganisms | CTLA-4 protein | Cell growth | Pathways | E coli | Intestine | Rodents | Surgery | Damage | Digestive tract | Deoxyribonucleic acid--DNA | Obesity | Liver diseases | Complications | Invasiveness | Inflammation | Patients | Survival | Cancer surgery | Studies | Probiotics | Diet | Antibiotics | Medical prognosis | Liver cirrhosis | Tumors
Journal Article
Hepatology, ISSN 0270-9139, 09/2014, Volume 60, Issue 3, pp. 858 - 871
Journal Article
2007, Gastroenterology clinics of North America, ISBN 1416050736, Volume 36, no. 4., xiii, p. 775-995
Book
Archives of Pathology and Laboratory Medicine, ISSN 0003-9985, 05/2016, Volume 140, Issue 5, pp. 437 - 448
Context.-Gastrointestinal (GI) and pancreatobiliary tracts contain a variety of neuroendocrine cells that constitute a diffuse endocrine system. Neuroendocrine... 
GANGLIOCYTIC PARAGANGLIOMA | MEDICINE, RESEARCH & EXPERIMENTAL | KI67 PROLIFERATIVE INDEX | RECTAL NEUROENDOCRINE | GASTROENTEROPANCREATIC SYSTEM | PATHOLOGY | ENDOCRINE NEOPLASIA TYPE-1 | PATHOLOGICAL CLASSIFICATION | LYMPH-NODE METASTASIS | IMMUNOHISTOCHEMICAL ANALYSIS | GOBLET-CELL CARCINOIDS | PROGNOSTIC-SIGNIFICANCE | MEDICAL LABORATORY TECHNOLOGY | Education, Medical, Continuing | Carcinoma, Neuroendocrine - diagnosis | Pancreatic Neoplasms - metabolism | Prognosis | Pancreatic Neoplasms - diagnosis | Humans | Neuroendocrine Tumors - diagnosis | Gastrointestinal Tract - pathology | Gastrointestinal Neoplasms - pathology | Mixed Tumor, Malignant - pathology | Neoplasm Grading | Biliary Tract - metabolism | Pathology, Clinical - manpower | Biliary Tract Neoplasms - metabolism | Biomarkers, Tumor - metabolism | Neuroendocrine Cells - metabolism | Mixed Tumor, Malignant - metabolism | Biliary Tract Neoplasms - pathology | Gastrointestinal Neoplasms - metabolism | Carcinoma, Neuroendocrine - metabolism | Neuroendocrine Tumors - pathology | Diagnosis, Differential | Neuroendocrine Cells - pathology | World Health Organization | Neuroendocrine Tumors - metabolism | Mixed Tumor, Malignant - diagnosis | Pancreatic Neoplasms - pathology | Pancreas - pathology | Gastrointestinal Neoplasms - diagnosis | Pancreas - metabolism | Biliary Tract Neoplasms - diagnosis | Gastrointestinal Tract - metabolism | Biliary Tract - pathology | Mitotic Index | Pathology, Clinical - methods | Carcinoma, Neuroendocrine - pathology | Pathology, Clinical - trends | Pathology, Clinical - education | Neoplasm Staging | Practice Guidelines as Topic | Tuberous sclerosis | Cancer
Journal Article
European Journal of Cancer, ISSN 0959-8049, 2014, Volume 50, Issue 18, pp. 3125 - 3135
Abstract Background Since sorafenib has shown activity in different tumour types and gemcitabine regimens improved the outcome for biliary tract cancer (BTC)... 
Hematology, Oncology and Palliative Medicine | Advanced biliary tract cancer | BTC | PDGFRβ | Hif1α | VEGFR-3 | c-kit | Sorafenib | VEGFR-2 | Hand-foot syndrome | ADVANCED HEPATOCELLULAR-CARCINOMA | CHOLANGIOCARCINOMA | COMBINATION THERAPY | GALLBLADDER CARCINOMA | OPEN-LABEL | OXALIPLATIN | Hif1 alpha | TRIAL | SKIN TOXICITY | ONCOLOGY | PDGFR beta | ADVANCED GASTRIC-CANCER | ENDOTHELIAL GROWTH-FACTOR | Niacinamide - analogs & derivatives | Prospective Studies | Humans | Middle Aged | Male | Hand-Foot Syndrome - etiology | Phenylurea Compounds - adverse effects | Biliary Tract Neoplasms - metabolism | Gallbladder Neoplasms - metabolism | Aged, 80 and over | Biomarkers, Tumor - metabolism | Adult | Bile Ducts, Intrahepatic | Deoxycytidine - adverse effects | Female | Biliary Tract Neoplasms - drug therapy | Bile Duct Neoplasms - drug therapy | Biliary Tract Neoplasms - pathology | Bile Duct Neoplasms - metabolism | Double-Blind Method | Drug Administration Schedule | Deoxycytidine - administration & dosage | Kaplan-Meier Estimate | Niacinamide - adverse effects | Vascular Endothelial Growth Factor Receptor-2 - metabolism | Treatment Outcome | Niacinamide - administration & dosage | Disease-Free Survival | Chemokine CXCL12 - metabolism | Gallbladder Neoplasms - drug therapy | Phenylurea Compounds - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Quality of Life | Vascular Endothelial Growth Factors - metabolism | Aged | Gallbladder Neoplasms - pathology | Bile Duct Neoplasms - pathology | Deoxycytidine - analogs & derivatives | Research | Gemcitabine | Oncology, Experimental | Cancer
Journal Article